Products are for professional/laboratory use only.
The immunoglobulin heavy-chain variable region gene (IgHV) mutational status is considered the gold standard for prognosis in chronic lymphocytic leukemia (CLL)1.
Abacus dx is pleased to inform you that the Invivoscribe LymphoTrack Dx IVD Assays are now available.
The Invivoscribe symposiums presented during the 25th European Hematology Association Virtual Congress are now available to watch on demand.
This webinar will explore how insights gained through NGS translate to the development of improved treatment of lymphoid malignancies.
Abacus dx is pleased to announce the launch of the new LymphoTrack B-cell Low Positive Controls and LymphoQuant B-cell Internal Controls as part of Invivoscribe’s MRD B-Cell Bundled Solution.